Global business process management (BPM) and customer experience (CX) outsourcing company offering voice, email, chat and omnichannel support plus AI data services such as data collection, annotation and labelling, serving telecom, retail, healthcare and BFSI clients across 15+ countries.
By the GenXT Labs Editorial Team · Last updated · Sourced from NSE, BSE, and the issue prospectus/RHP
Anchor bidding 13 Oct 2026 · Bid/offer 14–16 Oct 2026 · Allotment ~19 Oct · Listing ~22 Oct 2026 on NSE, BSE
Subscription
Closed (16 Oct, final) subscribed around 4.68x overall — retail ~5.99x, NII ~4.73x, QIB ~4.21x
Price band fixed at ₹275–₹289 per share for the ₹702 crore issue, comprising a ₹500 crore fresh issue and a ₹202 crore offer-for-sale by selling shareholders P N S Business and Rasish Consultants. Anchor book raised ₹315.90 Cr at the ₹289 upper price band ahead of the 14 Oct opening. Demand built through the issue before bidding closed 16 Oct at around 4.68x overall, led by retail at ~5.99x, with NII at ~4.73x and QIB at ~4.21x. Allotment expected to be finalised 19 Oct; listing tentatively 22 Oct on NSE and BSE.
What about GMP?
We don't track or publish a Grey Market Premium figure for Fusion CX — GMP is an unofficial, unregulated number that moves by the hour and is often wrong close to listing day. What's above instead is sourced directly from NSE/BSE filings and the issue's own prospectus, and we say plainly when a number is just a snapshot rather than live.
How to research this IPO
A checklist, not a verdict generator — work through these before forming your own view on Fusion CX.
What does the company actually do?
Get past the tagline — what specifically generates its revenue, and for whom?
How does it make money?
One dominant revenue line, or several? Which is growing, which is shrinking?
What does its financial history actually show?
Revenue and profit trend over 3+ years, not just the most recent flattering quarter.
What's happening in its industry right now?
Growing, mature, or under pressure — and is this IPO timed to ride a trend?
How does it compare to its listed peers?
Same growth rate, margins, and debt load — or is it being priced like a peer it doesn't actually resemble?
Is the asking valuation reasonable?
Compare its P/E, P/B, or EV/EBITDA at the IPO price band against listed peers — see our valuation primer.
What are the genuine strengths?
Market position, brand, distribution, technology — specific advantages, not marketing language.
What are the disclosed risks?
The prospectus's own "Risk Factors" section is required reading — it's where companies must legally disclose what could go wrong.
What would you still need to know?
Write down your open questions before applying — a genuine gap in your own understanding is a reason to wait, not to guess.
Issue size, price band, dates, and subscription figures for Fusion CX are sourced from public reporting at the time this page was last updated and are not live — always confirm current details on the exchange (NSE/BSE) or the issue's official RHP/prospectus before applying. Nothing on this page is investment advice or a recommendation to apply for, buy, sell, or hold any security. Always do your own research or consult a registered investment adviser before making financial decisions. See the full IPO tracker for every issue we're currently covering.